Topoisomerase I and II Inhibitors: A Patent Review

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 4, 2016-11 ,pp. : 401-423

Bentham Science Publishers

Access to resources Recommend Favorite

DNA-Topoisomerase I, a new target for the treatment of neuroblastoma

By Vassal G.   Pondarre C.   Cappelli C.   Terrier-Lacombe M.J.   Boland I.   Morizet J.   Benard J.   Venuat A.M.   Ardouin P.   Hartmann O.   Gouyette A.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2011-2015

Elsevier

Access to resources Recommend Favorite

Topoisomerase I Inhibitors in the Treatment of Primary CNS Malignancies: An Update on Recent Trends

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 9, 2010-01 ,pp. : 683-696

Bentham Science Publishers

Access to resources Recommend Favorite

Vorinostat enhances the cytotoxic effects of the topoisomerase I inhibitor SN38 in glioblastoma cell lines

By Sarcar Bhaswati   Kahali Soumen   Chinnaiyan Prakash  

Journal of Neuro-Oncology, Vol. 99, Iss. 2, 2010-09 ,pp. : 201-207

Springer Publishing Company

Access to resources Recommend Favorite

Apoptosis Induced by Topoisomerase Inhibitors

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 4, 2003-07 ,pp. : 271-290

Bentham Science Publishers

Access to resources Recommend Favorite